Medical devices safe from HTA in Germany – for now
This article was originally published in Clinica
Executive Summary
The German health service currently stands on the brink of a health technology assessment revolution. In accordance with the last Healthcare Reform Act of April 2007, from 1 September 2009 innovative pharmaceuticals that are entering the German market and require reimbursement will for the first time be subject to a cost/benefit evaluation. In essence, this does not appear to affect the medical devices industry, but the industry association, BVMed, is by no means being complacent.